Literature DB >> 24284090

An in vitro study on the photosensitivity of 5-aminolevulinic acid conjugated gold nanoparticles.

Zahra Mohammadi1, Ameneh Sazgarnia, Omid Rajabi, Samaneh Soudmand, Habibollah Esmaily, Hamid Reza Sadeghi.   

Abstract

BACKGROUND: In this study, the photosensitivity of 5-aminolevulinic acid (5-ALA) conjugated gold nanoparticles (conjugate) has been investigated on the MeL-Rm cell line.
METHODS: After culture and proliferation of the Mel-Rm cell line, cell toxicity and the suitable cell incubation time of the conjugate were determined. Photosensitivity of the conjugate and free 5-ALA was then studied in optical doses of 20, 40, 60 and 80 J/cm(2) while light irradiation was applied by a He-Ne laser.
RESULTS: A 4-h time interval was determined as the optimum incubation time for 5-ALA and the conjugate. PpIX induction into the cells showed a significant increase after incubation with the conjugate in comparison to 5-ALA alone. Also, the conjugate resulted in a two times higher cell death rate compared to free 5-ALA.
CONCLUSION: The conjugate can be used as an appropriate delivery agent for 5-ALA and provide efficient cell destruction during PDT.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-Aminolevulinic acid; Gold nanoparticle (GNP); Mel-Rm cell line.; Photodynamic therapy (PDT); Protoporphyrin IX (PpIX)

Mesh:

Substances:

Year:  2013        PMID: 24284090     DOI: 10.1016/j.pdpdt.2013.03.010

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  9 in total

1.  Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy.

Authors:  Connor Thunshelle; Rui Yin; Qiquan Chen; Michael R Hamblin
Journal:  Curr Dermatol Rep       Date:  2016-07-13

2.  Effect of ALA-PDT on inhibition of oral precancerous cell growth and its related mechanisms.

Authors:  Jian-Qiu Jin; Qian Wang; Yu-Xing Zhang; Xing Wang; Zhi-Yue Lu; Bo-Wen Li
Journal:  Lasers Med Sci       Date:  2022-07-07       Impact factor: 3.161

Review 3.  Combination of Fluorescence-Guided Surgery With Photodynamic Therapy for the Treatment of Cancer.

Authors:  Jun He; Leping Yang; Wenjun Yi; Wentao Fan; Yu Wen; Xiongying Miao; Li Xiong
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

Review 4.  Photodynamic Therapy for Metastatic Melanoma Treatment: A Review.

Authors:  Channay Naidoo; Cherie Ann Kruger; Heidi Abrahamse
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

5.  Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis.

Authors:  Yuya Kitajima; Takuya Ishii; Takeo Kohda; Masahiro Ishizuka; Kanami Yamazaki; Yumiko Nishimura; Tohru Tanaka; Shingo Dan; Motowo Nakajima
Journal:  Sci Rep       Date:  2019-06-17       Impact factor: 4.379

6.  Photo-Responsive Supramolecular Micelles for Controlled Drug Release and Improved Chemotherapy.

Authors:  Fasih Bintang Ilhami; Kai-Chen Peng; Yi-Shiuan Chang; Yihalem Abebe Alemayehu; Hsieh-Chih Tsai; Juin-Yih Lai; Yu-Hsuan Chiao; Chen-Yu Kao; Chih-Chia Cheng
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

7.  Detection of Canine Urothelial Carcinoma Cells in Urine Using 5-Aminolevulinic Acid.

Authors:  Kenjiro Kaji; Tomohiro Yonezawa; Yasuyuki Momoi; Shingo Maeda
Journal:  Animals (Basel)       Date:  2022-02-16       Impact factor: 2.752

8.  New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic-photothermal therapy.

Authors:  Zongjunlin Liu; Fang Xie; Jun Xie; Jianhao Chen; Yang Li; Qin Lin; Fanghong Luo; Jianghua Yan
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  One-Step Aqueous Synthesis of Anionic and Cationic AgInS2 Quantum Dots and Their Utility in Improving the Efficacy of ALA-Based Photodynamic Therapy.

Authors:  Mahshid Hashemkhani; Marilena Loizidou; Alexander J MacRobert; Havva Yagci Acar
Journal:  Inorg Chem       Date:  2022-02-01       Impact factor: 5.165

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.